VEECO INSTRUMENTS INC. (VECO): what the price assumes

In the published model solve dated 2026-Q2, anchored at $52.97, VEECO INSTRUMENTS INC. (VECO) is priced for today's economics sustained for ~24.2 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/VECO

Headline

FieldValue
TickerVECO
CompanyVEECO INSTRUMENTS INC.
Current price$52.97/sh
CompositionSemiconductor 72% / Compound Semiconductor 9% / Data Storage 6% / Scientific & Other 13%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Must persist for24.2y
Multiple paid177x operating income

Solve inputs: computed at a 11% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~3.1 years.

Reconcile: at the x-ray's 9.3% required return this reads ~19.2 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history-0.22σ
sustained it ~10 years at this level14%
implied end-window share0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset8.77x2expensive
Earnings8.38x1expensive
Relative5.88x2expensive
Growth—0—

Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.6%); the inversion above states its own rate.

Per-Model Detail (n=5)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$4.4511.90xnoFCF base $0.0B, growth -8% (input: historical growth), terminal g 0.5%, WACC 8.6%, 5yr projection
DCF Exit MultipleGrowth$32.781.62xnoExit EV/EBITDA: 82.3x / 84.3x / 86.3x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$15.353.45xyesP/E 39.6x (blended: static sector reference 18x + trailing (TTM) 138x), scenarios: 33.5x / 39.6x / 45.7x (bear / base = reference held flat / bull), EV/EBITDA 26.4x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$4.1412.79xyesBV/sh $14.63, ROE (TTM) 2.6%, ke 9.3%
Two-Stage Excess ReturnAsset$2.4121.98xyes5yr excess ROE then converge to ke=9.3% (excluded from median)
Discounted Future Market CapGrowth$21.272.49xnoRev $0.7B, growth -8% (input: historical growth; tapered), Terminal P/S: 4.1x / 4.9x / 5.6x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$7.167.40xnoNormalized EBIT (5y avg op income, one-time charges added back) $0.07B × (1−21%) / WACC 8.6% → EPV (no growth)
Residual IncomeAsset$1.7729.93xyesBV $14.63 + 5yr PV of (ROE (TTM) 2.6% − Kₑ 9.3%) × BV; BV grows 1.7%/yr (excluded from median)
Graham NumberAsset$11.184.74xyes√(22.5 × EPS $0.38 × BVPS $14.63) — Graham's conservative floor
EV/EBITDA RelativeRelative$6.378.32xyesEBITDA $0.04B × sector EV/EBITDA 12.0x
FCF YieldEarnings$6.328.38xyesFCF $42.9M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$0.015297.00xyesSBC-adj FCF $0.01B (FCF $0.04B − SBC $0.04B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarnings$0.32165.53xyesEPS $0.38 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$27.121.95xnoRevenue $0.66B × sector P/S 2.5x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$4.1112.89xnoEPS $0.38 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$130.6m
Net debt / NOPAT (after-tax)-8.75x (net cash)
Net debt / operating income (pre-tax)-6.91x (net cash)
Interest coverage2.4x
Share count CAGR (buyback)-1.9%
Burning cashno

Bullet Takeaways

Bull Case

Veeco's moat is narrow but deep: it makes specialized deposition and processing equipment that goes into the hardest steps of advanced chip manufacturing, the kind of tools where being best-in-class matters more than being cheapest. The company's filing puts its "proven TurboDisc technology" at the center of its MOCVD systems, describing it as "the key to enabling best-in-class deposition uniformity, yield performance and cost per wafer savings." When a chipmaker qualifies a tool into a production line, switching to a rival means requalifying an entire process, so incumbency in semiconductor capital equipment is sticky in a way few industrial businesses are. Veeco also has ion beam deposition systems under evaluation at leading DRAM memory makers and used to improve EUV lithography, placing it inside the most advanced and fastest-growing corners of the fab.

The reason to own a cyclical at a soft point is that the next up-cycle is taking shape in the order book, and Veeco's order book is pointing at artificial intelligence. The company secured over $250 million in orders for MOCVD, wet processing, and ion beam deposition tools to manufacture indium phosphide lasers, the optical components that move data inside AI data centers. Silicon photonics, where optical connectivity replaces copper between AI accelerators, is exactly the kind of new end-market that turns a mature equipment maker into a growth story. The filing also notes wins for "advanced wet processing and lithography systems from leading foundries," demand it ties directly to AI. Orders booked now convert to revenue as the tools ship over the coming quarters, which is why management guided second-quarter revenue up to $170 to $190 million and pointed to a stronger second half.

The balance sheet lets Veeco ride the cycle without distress. It holds a net cash position, roughly $383 million in liquid assets against $253 million of gross debt, so it can keep funding the research that keeps its tools best-in-class even when revenue dips. The first quarter was soft, with revenue of $158 million and adjusted earnings of $0.14, but the company stayed profitable on a non-GAAP basis through the trough. The bull bet is that the trailing numbers reflect a cyclical low, the AI-driven silicon-photonics and memory demand is real and already showing up in orders, and a financially sound equipment maker with qualified positions at leading fabs is set to inflect as the next up-cycle arrives.

Bear Case

Veeco is a small equipment maker whose demand is set by a handful of giant customers in a handful of countries, and that narrow base is the structural risk. The filing is candid that reliance on "customer demand arising primarily from a limited number of countries could materially" affect the business, and that US export approval requirements "pose a particular disadvantage to the Company relative to certain of our non-U.S. competitors and increase our exposure to foreign and Chinese domestic competition." That is a precise statement of two compounding threats: Veeco depends on a concentrated set of buyers, and the regulations governing what it can sell to China both cost it orders and hand its Chinese rivals room to grow. Semiconductor capital equipment is also brutally cyclical, with order patterns that swing hard as fabs accelerate and then pause capital spending, and the company sits at the volatile front end of that cycle.

The recent results show how quickly the operating line moves. First-quarter revenue fell to $158 million from $167 million a year earlier, the company posted a small GAAP net loss against net income a year before, non-GAAP earnings roughly halved, and the $0.14 result missed the $0.19 consensus by more than a quarter. The semiconductor segment, about 69% of revenue, declined. These are the numbers a buyer is actually paying for today, and against them the price looks expensive on every conventional measure: no valuation family reaches it. With trailing operating margin compressed near 3% at the cycle low, the price embeds a recovery that has to be both large and durable, and the model reads that implied bet as requiring the business to sustain elevated economics for an implausibly long horizon.

The structural balance-sheet point is subtler than leverage, because Veeco has little net debt; it is the operating fragility under a high-fixed-cost equipment model. Building complex deposition tools carries heavy engineering and manufacturing overhead that does not flex down with revenue, so a cyclical downturn or a delayed up-cycle compresses margins fast, as the recent quarter showed. The much-cited AI order momentum is real but it is also concentrated and lumpy: a single large customer pushing out a tool delivery, or an export restriction blocking a shipment, can move a quarter materially. The bear case is that the buyer is paying a full price for a cyclical, geographically exposed equipment maker at a moment when trailing earnings are depressed, betting that the AI-driven recovery arrives on schedule and lasts, against a method set that unanimously calls the current price expensive and a regulatory backdrop that openly favors the company's foreign competitors.

Valuation

Veeco is a cyclical equipment maker priced for a recovery, and the methods all say the recovery is not yet in the trailing numbers. Sorted by what they measure, no family reaches today's price near $80 (June 28, 2026): asset value, trailing earnings power, and peer multiples all land below it, several far below, and the growth lens has too little to work with at the cycle low to even register a read. The honest interpretation is partly an artifact of where the cycle sits, because trailing operating margin is compressed near 3% at a trough, and partly a genuine warning that the price already credits a substantial rebound.

The inversion makes the demand explicit and flags its fragility. Read against current depressed economics, the price implies the company sustaining a much higher level of profitability for an extraordinarily long horizon, well beyond what the historical fade rate supports, which is why the model's fair-value range here carries low reliability. That low reliability is the signal: with trailing earnings near a cyclical bottom, no method can cleanly anchor the price, so the valuation rests entirely on the conviction that the AI-driven order book translates into a real and lasting margin recovery. The roughly $250 million of recent silicon-photonics orders is exactly the forward evidence the trailing methods cannot see, and the gap between that order momentum and the soft income statement is what a buyer is paying for.

Solvency keeps the cyclicality from becoming existential. Veeco holds about $383 million in liquid assets against $253 million of gross debt, a net cash position, so the balance sheet is not the risk; the cycle and the geography are. Inside the semiconductor and industrial-equipment cohort, the relevant comparison is other capital-equipment makers whose fortunes ride the same fab-spending cycle, and Veeco's distinction is its concentration in deposition and processing tools tied to compound semiconductors and optical connectivity. The bet reconciles to paying a full price during a trough quarter for a financially sound, technically strong equipment maker, on the condition that the AI and memory order momentum converts into the durable earnings recovery the price already assumes, despite export-control headwinds the company concedes favor its competitors.

Catalysts

The first quarter was the trough the bull case needs to be temporary. Veeco reported first-quarter 2026 revenue of $158 million, down from $167 million a year earlier, with a small GAAP net loss, non-GAAP net income of $8.9 million, and adjusted EPS of $0.14 that missed the $0.19 consensus. The semiconductor segment, roughly 69% of revenue, declined, reflecting the broader pause in fab capital spending.

The forward signals are firmer than the trailing print. Management guided second-quarter revenue to a range of $170 to $190 million with EPS of $0.20 to $0.32, and full-year 2026 revenue to $740 to $800 million, explicitly expecting stronger growth in the second half driven by compound-semiconductor and AI-related demand. The concrete underpinning is the order book: over $250 million in orders for MOCVD, wet processing, and ion beam deposition tools to make indium phosphide lasers for optical transceivers, plus wins for advanced wet processing and lithography systems from leading foundries.

The swing variables are silicon-photonics adoption and the China export backdrop. Stronger optical connectivity requirements in AI data centers are the demand driver management is leaning on, while US export approval requirements remain a constraint that can delay or block shipments and aid foreign competitors. The next checkpoint is the second-quarter print in mid-2026, which will show whether the guided sequential revenue step-up and the second-half acceleration began to materialize against the AI order momentum.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, May 5 2026

View the full interactive VECO report on boothcheck